This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
Item | Value |
---|---|
Country | United States |
Wikipedia page | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
Best overview URL | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
Facebook username | gatesfoundation |
LinkedIn username | bill-&-melinda-gates-foundation |
Website | https://www.gatesfoundation.org/ |
Donations URL | https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database |
Twitter username | gatesfoundation |
Page on philosophy informing donations | https://www.gatesfoundation.org/What-We-Do |
Grant application process page | https://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ |
Regularity with which donor updates donations data | continuous updates |
Regularity with which Donations List Website updates donations data (after donor update) | irregular |
Lag with which donor updates donations data | months |
Lag with which Donations List Website updates donations data (after donor update) | years |
Data entry method on Donations List Website | SQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing |
Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett
Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief
Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database
Full donor page for donor Bill and Melinda Gates Foundation
Item | Value |
---|---|
Country | |
Facebook page | uclofficial |
Website | http://www.ucl.ac.uk/ |
Twitter username | ucl |
Wikipedia page | https://en.wikipedia.org/wiki/University_College_London |
Instagram username | ucl |
Medium username | ucl-antenna |
Org Watch page | https://orgwatch.issarice.com/?organization=University+College+London |
Full donee page for donee University College London
Item | Value |
---|
Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | 35 | 228,680 | 1,707,901 | -58,236 | 0 | 84,436 | 100,000 | 100,000 | 228,680 | 333,572 | 664,241 | 750,000 | 1,499,182 | 25,334,158 |
Global health | 26 | 251,100 | 2,226,395 | -58,236 | 0 | 100,000 | 100,000 | 175,000 | 251,100 | 632,226 | 750,000 | 968,889 | 5,909,061 | 25,334,158 |
Sanitation | 3 | 4,200 | 32,433 | -6,902 | 0 | 0 | 0 | 4,200 | 4,200 | 4,200 | 100,000 | 100,000 | 100,000 | 100,000 |
Nutrition | 6 | 175,000 | 298,829 | 84,436 | 84,436 | 100,000 | 100,000 | 175,000 | 175,000 | 333,572 | 349,968 | 349,968 | 750,000 | 750,000 |
If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.
Note: Cause area classification used here may not match that used by donor for all cases.
Cause area | Number of donations | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global health (filter this donor) | 26 | 57,886,265.87 | 228,680.00 | 1,836,530.00 | 18,420,648.00 | 1,816,492.50 | -40,788.00 | 5,909,061.00 | 1,629,140.00 | 1,499,182.00 | 1,053,162.37 | 200,000.00 | 25,334,158.00 |
Nutrition (filter this donor) | 6 | 1,792,975.50 | 0.00 | 333,572.00 | 750,000.00 | 624,967.50 | 84,436.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sanitation (filter this donor) | 3 | 97,298.30 | 0.00 | 0.00 | 0.00 | 0.00 | -6,901.70 | 0.00 | 4,200.00 | 100,000.00 | 0.00 | 0.00 | 0.00 |
Total | 35 | 59,776,539.67 | 228,680.00 | 2,170,102.00 | 19,170,648.00 | 2,441,460.00 | 36,746.30 | 5,909,061.00 | 1,633,340.00 | 1,599,182.00 | 1,053,162.37 | 200,000.00 | 25,334,158.00 |
Graph of spending by cause area and year (incremental, not cumulative)
Graph of spending by cause area and year (cumulative)
There are no documents associated with this combination of donor and donee.
Graph of all donations (with known year of donation), showing the timeframe of donations
Amount (current USD) | Amount rank (out of 35) | Donation date | Cause area | URL | Influencer | Notes |
---|---|---|---|---|---|---|
228,680.00 | 18 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the immunogenicity and impact of a reduced 13 valent pneumococcal conjugate vaccine (PCV13) dosing schedule; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
632,226.00 | 12 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to develop a freely available web-based tool that synthesizes existing evidence and helps countries make informed choices about funding allocation for health benefits and contributes to minimizing health burden, maximizing equity and ensuring financial ri; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
883,575.00 | 7 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support a mixed methods evaluation of MTV’s Shuga series V into the BMGF-funded impact evaluation of DREAMS; Aid type: Project-type interventions. Affected countries: South Africa. | |
45,393.00 | 30 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to populate the data from additional 10 excipients and update the existing data in the Safety and Toxicity of Excipients for Paediatric (STEP) database; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
333,572.00 | 15 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
333,572.00 | 15 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-58,236.00 | 35 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to model the population level effects of availability of potential new HIV diagnostic technology with defined specifications in order to generate a target product profile for one or more potential new diagnostic tools; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
17,670,648.00 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to create a new manufacturing platform to enable ultra-low cost, high quality, recombinant subunit vaccines at 15¢ a dose for global health initiatives; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
750,000.00 | 8 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
750,000.00 | 8 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to improve treatment for children with pneumonia and malnutrition by using bioelectric impedance vector analysis (BIVA) to more accurately measure nutritional status; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
175,000.00 | 19 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
175,000.00 | 19 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
251,100.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the International Symposium on Pneumococci and Pneumococcal Diseases, the international pneumococcal experts meeting held in Glasgow, Scotland in June 2016; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-28,464.00 | 33 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to support an exploratory study to guide the design of an emollient field trial in Africa; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
349,967.50 | 13 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
349,967.50 | 13 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to chart the nature and pace of neurocognitive development from birth to 24 months of age in infants and children from the UK and sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to reduce child fatalities from pneumonia in developing countries by adapting the antibiotic amoxicillin to be administered rectally rather than as an unpleasant tasting tablet, and for long-term storage in hot climates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
968,889.00 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the immunogenicity and impact of a reduced 13 valent pneumococcal conjugate vaccine (PCV13) dosing schedule; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
-6,901.70 | 32 | Sanitation/basic sanitation | https://iatiregistry.org/publisher/bmgf | -- | to develop a simulation tool that can be used in developing communities that have non-networked sanitation systems to effectively evaluate new sanitation technologies.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
84,436.00 | 29 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to assess the trajectory and causes of growth faltering in children in Dhanusha district, Nepal, whose growth patterns are heavily influenced by monsoon seasonality. These findings will help characterize and quantify different patterns of growth and devel; Aid type: Project-type interventions. Affected countries: Nepal. | |
-40,788.00 | 34 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to fund a vaccine discovery (antibody) consortium. UCL VDAC Consortium: Vaccine induced protective cross-neutralization of HIV-1. Investment start date: 7/1/2006 to end date: 6/30/2013. Grantee name: University College London; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
5,909,061.00 | 3 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to allow the use of new molecular epidemiology tools to explore the drivers of epidemics, specifically focusing on the relative importance of key populations in generalized epidemics and to support the testing of samples from African populations; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
100,000.00 | 21 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to develop and validate a low-cost, low-technology whole body cooling device that operates on a proven servo-controlled algorithm to reduce death and disability resulting from neonatal encephalopathy.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
664,241.00 | 11 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to model the population level effects of availability of potential new HIV diagnostic technology with defined specifications in order to generate a target product profile for one or more potential new diagnostic tools; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
664,899.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to study the pattern and severity of childhood pneumonia before and after pneumococcal vaccination, evaluate the vaccine status of children with severe illnesses, and analyze the cost effectiveness of the pneumococcal vaccine in Malawi; Aid type: Project-type interventions. Affected countries: Malawi. | |
4,200.00 | 31 | Sanitation/basic sanitation | https://iatiregistry.org/publisher/bmgf | -- | to develop a simulation tool that can be used in developing communities that have non-networked sanitation systems to effectively evaluate new sanitation technologies.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to apply a new liquid stabilizing technology to create thermostable vaccines that can withstand extremes of temperature and eliminate the need for a cold chain.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to use a non-invasive optical brain imaging technology (near-infrared spectroscopy) to study cognitive function in malnourished infants and children.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
100,000.00 | 21 | Sanitation/basic sanitation | https://iatiregistry.org/publisher/bmgf | -- | to develop a simulation tool that can be used in developing communities that have non-networked sanitation systems to effectively evaluate new sanitation technologies.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
1,499,182.00 | 4 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to study the pattern and severity of childhood pneumonia before and after pneumococcal vaccination, evaluate the vaccine status of children with severe illnesses, and analyze the cost effectiveness of the pneumococcal vaccine in Malawi; Aid type: Project-type interventions. Affected countries: Malawi. | |
1,053,162.37 | 5 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to support an exploratory study to guide the design of an emollient field trial in Africa; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
100,000.00 | 21 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to target an essential bacterial nutrient transport system with an iron-binding nanoparticle to carry antibiotics that can be released in the vicinity of bacterium; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
100,000.00 | 21 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to attempt to stimulate an antibody response against a protein found in the body which is used by HIV to infect cells, and overcome natural tolerance of CCR5 to deplete the presence of the protein and prevent a way for HIV to enter cells; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
25,334,158.00 | 1 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to fund a vaccine discovery (antibody) consortium. UCL VDAC Consortium: Vaccine induced protective cross-neutralization of HIV-1. Investment start date: 7/1/2006 to end date: 6/30/2013. Grantee name: University College London; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |